The analysis used the US National Inpatient Sample for 2016-2023, covering 63,755 weighted hospitalisations for STEMI with cardiogenic shock treated with mechanical circulatory support. Crude in-hospital mortality rose from 30.7% with no chronic kidney disease to 40.7% at stages 4-5 or end-stage disease. The adjusted odds ratio for death with advanced disease was 1.26, and acute kidney injury affected 87.6% of that group.
Why it is interesting: Sets the size of the kidney disease gradient in shock after STEMI, from coding rather than clinical records.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.